A

Andlauer Healthcare Group Inc
TSX:AND

Watchlist Manager
Andlauer Healthcare Group Inc
TSX:AND
Watchlist
Price: 54.97 CAD 0.02% Market Closed
Market Cap: 2.2B CAD
Section:
 

Relative Value

The Relative Value of one AND stock under the Base Case scenario is 47.02 CAD. Compared to the current market price of 54.97 CAD, Andlauer Healthcare Group Inc is Overvalued by 14%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AND Relative Value
Base Case
47.02 CAD
Overvaluation 14%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

3.3
P/S
P/S
Price to Sales
3.3
vs History
38
vs Industry
44
Median 3Y
2.7
Median 5Y
3.2
Industry
2.3
Forward
3.3
More Details
31.9
P/E
P/E
Price to Earnings
31.9
vs History
20
vs Industry
24
Median 3Y
25.4
Median 5Y
25.5
Industry
22.5
Forward
32.7
More Details
17.6
P/OCF
P/OCF
Price to OCF
17.6
vs History
34
vs Industry
31
Median 3Y
14.6
Median 5Y
16.7
Industry
14.5
More Details
38.3
P/FCFE
P/FCFE
Price to FCFE
38.3
vs History
28
vs Industry
28
Median 3Y
35.4
Median 5Y
28.7
Industry
21.5
More Details
4.9
P/B
P/B
Price to Book Value
4.9
vs History
38
vs Industry
25
Median 3Y
4.1
Median 5Y
4.7
Industry
2.2
More Details
3.4
EV/S
EV/S
Enterprise Value to Sales
3.4
vs History
39
vs Industry
43
Median 3Y
2.7
Median 5Y
3.2
Industry
2.6
Forward
3.3
More Details
9.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.9
vs History
0
vs Industry
31
Median 3Y
6.4
Median 5Y
7.5
Industry
5.2
More Details
13.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.4
vs History
38
vs Industry
34
Median 3Y
10.7
Median 5Y
12.8
Industry
11.9
Forward
13.2
More Details
23.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
23.8
vs History
33
vs Industry
27
Median 3Y
18.2
Median 5Y
21.8
Industry
16.9
Forward
23.5
More Details
17.9
EV/OCF
EV/OCF
Enterprise Value to OCF
17.9
vs History
34
vs Industry
31
Median 3Y
15
Median 5Y
17.1
Industry
14.7
More Details
22
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
22
vs History
31
vs Industry
28
Median 3Y
19.8
Median 5Y
21
Industry
18.7
More Details
3.7
EV/IC
EV/IC
Enterprise Value to IC
3.7
vs History
23
vs Industry
30
Median 3Y
3.1
Median 5Y
3.4
Industry
1.9
More Details

Multiples Across Competitors

AND Competitors Multiples
Andlauer Healthcare Group Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Andlauer Healthcare Group Inc
TSX:AND
2.2B CAD 3.3 31.9 13.4 23.8
US
CVS Health Corp
NYSE:CVS
102.7B USD 0.3 218.9 14.2 14.2
US
Cigna Corp
NYSE:CI
72.6B USD 0.3 11.8 7.6 9.7
US
Cigna Group
XMUN:CGN
60.4B EUR 0.3 11.5 7.5 9.5
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.1B EUR 1.2 23.7 10.4 15.8
DE
Fresenius Medical Care AG
XMUN:FME
23.4B EUR 1.2 32.5 10.3 21.9
US
Laboratory Corporation of America Holdings
NYSE:LH
22B USD 1.6 25.7 13.9 19.4
US
Quest Diagnostics Inc
NYSE:DGX
20.2B USD 1.9 20.9 11.5 15.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.6B EUR 0.6 16.1 6.4 13.6
US
Guardant Health Inc
NASDAQ:GH
12.7B USD 14 -31.8 -33.6 -30.5
US
DaVita Inc
NYSE:DVA
8.5B USD 0.6 11.1 6.8 9.3

See Also

Summary
AND intrinsic value, competitors valuation, and company profile.
DCF Valuation
AND stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AND stock valuation using valuation multiples.
Wall Street Estimates
AND price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AND stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 302,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.